Stock PFND PATHFINDER CELL THERAPY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Quotes Pathfinder Cell Therapy, Inc.

Equities

PFND

US70319A1060

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 11:22:12 2024-03-14 EDT 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Pathfinder Cell Therapy, Inc. -.--% -.--%
2015 Pathfinder Cell Therapy, Inc. Auditor Raises 'Going Concern' Doubt CI

Volumes

markets
Daily volume
500
Estimated daily volume
500
Record volume 1
4 507 415
Record volume 2
3 679 025
Record volume 3
1 752 829
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (USD)
667
Net sales ()
0
Number of employees
1
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
100 %
Free-Float capitalization (USD)
667

Highs and lows

3 years
0.00
Extreme 0
0.03
5 years
0.00
Extreme 0
0.03
10 years
0.00
Extreme 0
0.05

Indicators

RSI 9 days
0.00
RSI 14 days
0.00

Sector Comparison - Other Biotechnology & Medical Research

Name Change 5d. change 1st Jan change 1-year change Capi.
PATHFINDER CELL THERAPY, INC. Stock Pathfinder Cell Therapy, Inc.
-.--%-.--% - - 667
MODERNA, INC. Stock Moderna, Inc.
-5.89%-14.43%+43.36%+11.64% 54.64B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.51%-4.58%-5.31%+11.26% 39.92B
LONZA GROUP AG Stock Lonza Group AG
-0.45%-5.59%+37.52%-14.58% 38.82B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+0.59%+1.28%+14.75%+52.48% 26.86B
CELLTRION, INC. Stock Celltrion, Inc.
-0.62%-2.06%-12.56%+2.86% 26.22B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-1.07%+0.45%-22.45%-19.77% 18.78B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+1.73%+0.82%+25.12%+31.18% 12.21B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-0.08%-4.46%+0.04%-5.62% 12.16B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+0.17%-1.08%+26.04%+86.66% 11.94B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-0.61%-4.04%-11.83%+7.79% 10.74B
QIAGEN N.V. Stock Qiagen N.V.
+1.45%-1.07%-3.38%-7.08% 9.6B
BACHEM HOLDING AG Stock Bachem Holding AG
-1.82%-6.48%+24.38%-15.43% 6.71B
BLUEPRINT MEDICINES CORPORATION Stock Blueprint Medicines Corporation
-0.75%+2.67%+14.44%+86.77% 6.61B
REVOLUTION MEDICINES, INC. Stock Revolution Medicines, Inc.
+0.42%+1.00%+33.65%+53.75% 6.32B
WCG CLINICAL, INC. Stock WCG Clinical, Inc.
-.--%-.--% - - 6.07B
Average-0.53%-2.34%+11.70%+20.14%
Weighted average by Cap.-1.41%-4.61%+14.88%+13.52%

Historical data

DateOpeningHighLowEnd-of-dayVolume

Chart Pathfinder Cell Therapy, Inc.

Chart Pathfinder Cell Therapy, Inc.
More charts

Monthly variations

Annual change

2024-.--%
2023-.--%
2022-.--%
2021-99.95%
2020-9.52%
2019+75.00%
2018-43.13%
2017+163.75%
2016-74.19%
2015+287.50%
2014-94.29%
2013-30.00%
2012-60.00%
2011-9.09%
  1. Stock Market
  2. Equities
  3. PFND Stock
  4. Quotes Pathfinder Cell Therapy, Inc.